Fusion Antibodies plc (AIM: FAB)
Health Care · Life Sciences Tools & Services · GB
£0.10
-2.50% today · -25.9% 1Y
Fusion Antibodies plc (AIM: FAB) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $16.56M.
Over the last twelve months the share price has lost 25.9%, trading between 0.09 and 0.20.
Tweenvest scores Fusion Antibodies plc across four factors: quality 44/100, value 56/100, growth 69/100. Its strongest factor is growth.
FAB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $16.56M
- Revenue (TTM)
- $2.79M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.28
- 52-week high
- £0.20
- 52-week low
- £0.09
- Avg volume (3M)
- —
- Shares outstanding
- 125.16M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Oxford BioDynamics PlcAIM: OBD | $17.79M | £0.00 | -13.04% |
| Veritas In Silico Inc.TSE: 130A | $17.45M | ¥426.00 | -1.84% |
| Jeevan Scientific Technology LimitedBSE: 538837 | $17.35M | Rs83.60 | -1.31% |
| Bionano Genomics, Inc.NasdaqCM: BNGO | $16.90M | $1.32 | -8.01% |
| Proteomics International Laboratories LtdASX: PIQ | $14.43M | AU$0.13 | +4.17% |
| Genetic Signatures LimitedASX: GSS | $13.31M | AU$0.08 | +6.33% |
| Malaysian Genomics Resource Centre BerhadKLSE: MGRC | $12.93M | RM0.35 | -2.78% |
| Welgene Biotech Co.,Ltd.TPEX: 6661 | $12.58M | NT$17.20 | +6.17% |
Figures last refreshed Oct 11, 2026.